Novel Interdisciplinary Approach to GERD: Concomitant Laparoscopic Hiatal Hernia Repair with Transoral Incisionless Fundoplication
- 17 December 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American College of Surgeons
- Vol. 232 (3), 309-318
- https://doi.org/10.1016/j.jamcollsurg.2020.11.021
Abstract
Background Transoral incisionless fundoplication (TIF) is an endoscopic alternative for the treatment of GERD. However, TIF does not address the hiatal hernia (HH). We present a novel approach with a laparoscopic HH repair followed by same-session TIF, coined concomitant transoral incisionless fundoplication (cTIF). The aim of this study was to assess the efficacy, safety, and feasibility of cTIF in a collaborative approach between Gastroenterology and surgery. Study Design Patients with confirmed GERD and >2 cm HH who underwent cTIF between 2018 and 2020 were included. Symptoms were assessed using the Reflux Disease Questionnaire, GERD Health-Related Quality of Life Index, and the Reflux Symptom Index pre and post cTIF. One-way ANOVA and paired samples t-test were used for statistical analysis. Results Sixty patients underwent cTIF (53% were men, mean age was 59.3 years) with 100% technical success. Mean ± SD HH measurement on endoscopy was 2.9 ± 1.5 cm. Scores on Reflux Disease Questionnaire for symptom frequency and symptom severity improved significantly from before to 6 months after cTIF (17.4 to 4.72; p < 0.01 and 16.7 to 4.56; p < 0.05, respectively). According to the GERD Health-Related Quality of Life Index, significant decreases were seen post cTIF in heartburn (23.26 to 7.37; p < 0.01) and regurgitation (14.26 to 0; p = 0.05). Reflux Symptom Index similarly decreased after cTIF (17.7 to 8.1 post cTIF; p < 0.01). Mean DeMeester score decreased from 43.7 to 4.9 and acid exposure time decreased from 12.7% to 1.28% post cTIF (p = 0.06). Conclusions We present a novel multidisciplinary approach to GERD using a combined endoscopic and surgical approach with close collaboration between Gastroenterology and surgery. Our results suggest that cTIF is safe and effective in reducing reflux symptoms in a large spectrum of GERD patients.This publication has 29 references indexed in Scilit:
- Laparoscopic anti-reflux revision surgery after transoral incisionless fundoplication is safe and effectiveSurgical Endoscopy, 2014
- Long-term cost-effectiveness of medical, endoscopic and surgical management of gastroesophageal reflux diseaseSurgery, 2014
- Transoral Incisionless Fundoplication Effective in Eliminating GERD Symptoms in Partial Responders to Proton Pump Inhibitor Therapy at 6 MonthsSurgical Innovation, 2014
- The Effects of Transoral Incisionless Fundoplication on Chronic GERD PatientsSurgical Laparoscopy, Endoscopy & Percutaneous Techniques, 2014
- A Prospective Multicenter Registry of Patients with Chronic Gastroesophageal Reflux Disease Receiving Transoral Incisionless FundoplicationJournal of the American College of Surgeons, 2012
- Three-Year Results of a Multicenter Prospective Study of Transoral Incisionless FundoplicationSurgical Innovation, 2012
- Short-term safety and symptomatic outcomes of transoral incisionless fundoplication with or without hiatal hernia repair in patients with chronic gastroesophageal reflux diseaseThe American Journal of Surgery, 2011
- Effect of Transoral Incisionless Fundoplication on Symptoms, PPI Use, and pH‐Impedance Refluxes of GERD PatientsWorld Journal of Surgery, 2010
- Two-year results of a feasibility study on antireflux transoral incisionless fundoplication using EsophyXSurgical Endoscopy, 2009
- Antireflux Transoral Incisionless Fundoplication Using EsophyX: 12‐Month Results of a Prospective Multicenter StudyWorld Journal of Surgery, 2008